Drug Type Small molecule drug |
Synonyms 9-(2-(phosphonomethoxy)ethyl)adenine, 9-(2-phosphonylmethoxyethyl)adenine, Adefovir (USAN/INN) + [6] |
Target |
Mechanism HBV pol inhibitors(HBV DNA Polymerase inhibitors), Cell differentiation stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC8H12N5O4P |
InChIKeySUPKOOSCJHTBAH-UHFFFAOYSA-N |
CAS Registry106941-25-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 3 | US | - | |
Hepatitis B | Phase 2 | - | - |
Phase 2 | 41 | (Lamivudine and Adefovir) | - View more | - | 04 Apr 2013 | ||
(Adefovir) | |||||||
Not Applicable | Hepatitis B | HIV Infections HIV antibody | hepatitis B surface antibody (HBsAb) | hepatitis B core antibody (HBcAb) ... View more | - | Adefovir 10mg daily and famciclovir 500mg t.d.s | zeddectdmm(lcffsnuvbm) = zfzjzcunbq lidreqgjar (hpcbrjgjdo ) View more | - | 01 Jan 2007 |